0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-01-01 Sage Accounts Production Advanced 2023 - FRS102_2023 240,000 240,000 240,000 xbrli:pure xbrli:shares iso4217:GBP 11097500 2023-01-01 2023-12-31 11097500 2023-12-31 11097500 2022-12-31 11097500 2022-01-01 2022-12-31 11097500 2022-12-31 11097500 2021-12-31 11097500 core:NetGoodwill 2023-01-01 2023-12-31 11097500 bus:Director1 2023-01-01 2023-12-31 11097500 core:WithinOneYear 2023-12-31 11097500 core:WithinOneYear 2022-12-31 11097500 core:ShareCapital 2023-12-31 11097500 core:ShareCapital 2022-12-31 11097500 core:RetainedEarningsAccumulatedLosses 2023-12-31 11097500 core:RetainedEarningsAccumulatedLosses 2022-12-31 11097500 core:NetGoodwill 2023-12-31 11097500 core:NetGoodwill 2022-12-31 11097500 bus:SmallEntities 2023-01-01 2023-12-31 11097500 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 11097500 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 11097500 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 11097500 bus:FullAccounts 2023-01-01 2023-12-31
COMPANY REGISTRATION NUMBER: 11097500
DENTAL IMPLANT SOLUTIONS LIMITED
FILLETED UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 December 2023
DENTAL IMPLANT SOLUTIONS LIMITED
STATEMENT OF FINANCIAL POSITION
31 December 2023
2023
2022
Note
£
£
£
FIXED ASSETS
Intangible assets
4
240,000
240,000
CURRENT ASSETS
Debtors
5
1,144
1,133
Cash at bank and in hand
72,943
44,573
--------
--------
74,087
45,706
CREDITORS: amounts falling due within one year
6
313,102
284,590
----------
----------
NET CURRENT LIABILITIES
239,015
238,884
----------
----------
TOTAL ASSETS LESS CURRENT LIABILITIES
985
1,116
----
-------
CAPITAL AND RESERVES
Called up share capital
100
100
Profit and loss account
885
1,016
----
-------
SHAREHOLDERS FUNDS
985
1,116
----
-------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
DENTAL IMPLANT SOLUTIONS LIMITED
STATEMENT OF FINANCIAL POSITION (continued)
31 December 2023
These financial statements were approved by the board of directors and authorised for issue on 31 January 2024 , and are signed on behalf of the board by:
Dr A Nesbitt
Director
Company registration number: 11097500
DENTAL IMPLANT SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 31 DECEMBER 2023
1. GENERAL INFORMATION
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is The Orangery Rangemore Gardens, Rangemore, Burton on Trent, DE13 9RG.
2. STATEMENT OF COMPLIANCE
These financial statements have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. ACCOUNTING POLICIES
(a) Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
(b) Going concern
In March 2020 the UK was impacted by the outbreak of Covid-19. The Government imposed significant restrictions at that time in an effort to manage the spread of the virus which resulted in the company having to review and change its working practices to ensure compliance with these restrictions. More latterly, the UK economy has been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
(c) Current & deferred tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
(d) Goodwill
Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight-line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.
(e) Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
(f) Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
4. INTANGIBLE ASSETS
Goodwill
£
Cost
At 1 January 2023 and 31 December 2023
240,000
----------
Amortisation
At 1 January 2023 and 31 December 2023
----------
Carrying amount
At 31 December 2023
240,000
----------
At 31 December 2022
240,000
----------
5. DEBTORS
2023
2022
£
£
Other debtors
1,144
1,133
-------
-------
6. CREDITORS: amounts falling due within one year
2023
2022
£
£
Amounts owed to group undertakings
5,477
( 2,834)
Corporation tax
1,846
3,091
Directors loan account
305,779
284,333
----------
----------
313,102
284,590
----------
----------
7. RELATED PARTY TRANSACTIONS
During the year the Directors loaned the Company £ 305,779 (2022 : £ 284,333 ). This amount incurred interest at the end of each month, in line with the Bank of England base rate. This amount was also repayable upon demand.